METTL3 and non-small cell lung carcinoma: Additionally, CAF-derived VEGFA upregulates METTL3 in NSCLC cells and activates the AKT/NF-κB pathway via RAC3, further promoting m6A methylation and enhancing tumor migration and invasion (143).